skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:053708/0635   Pages: 5
Recorded: 09/04/2020
Attorney Dkt #:BBI TO SDPO NAME CHANGE
Conveyance: CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Total properties: 18
1
Patent #:
Issue Dt:
11/04/2014
Application #:
12677511
Filing Dt:
01/03/2011
Publication #:
Pub Dt:
05/12/2011
Title:
NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS
2
Patent #:
Issue Dt:
08/29/2017
Application #:
12677513
Filing Dt:
03/20/2012
Publication #:
Pub Dt:
10/04/2012
Title:
NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS
3
Patent #:
Issue Dt:
08/15/2017
Application #:
12677516
Filing Dt:
08/12/2010
Publication #:
Pub Dt:
12/09/2010
Title:
NOVEL COMPOSITIONS AND METHODS FOR CANCER TREATMENT
4
Patent #:
Issue Dt:
08/15/2017
Application #:
13634694
Filing Dt:
10/16/2012
Publication #:
Pub Dt:
01/31/2013
Title:
NOVEL METHODS FOR TARGETING CANCER STEM CELLS
5
Patent #:
Issue Dt:
12/05/2017
Application #:
14499299
Filing Dt:
09/29/2014
Publication #:
Pub Dt:
01/15/2015
Title:
NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS
6
Patent #:
Issue Dt:
07/10/2018
Application #:
15116850
Filing Dt:
08/05/2016
Publication #:
Pub Dt:
06/22/2017
Title:
3-SUBSTITUTED CARBONYL-NAPHTHO[2,3-B]FURANE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
7
Patent #:
Issue Dt:
05/12/2020
Application #:
15981406
Filing Dt:
05/16/2018
Publication #:
Pub Dt:
11/22/2018
Title:
METHODS FOR TREATING CANCER
8
Patent #:
NONE
Issue Dt:
Application #:
16130857
Filing Dt:
09/13/2018
Publication #:
Pub Dt:
08/15/2019
Title:
CELL CULTURES AND USE THEREOF
9
Patent #:
Issue Dt:
12/01/2020
Application #:
16161413
Filing Dt:
10/16/2018
Publication #:
Pub Dt:
08/29/2019
Title:
NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS
10
Patent #:
Issue Dt:
06/16/2020
Application #:
16204730
Filing Dt:
11/29/2018
Publication #:
Pub Dt:
08/08/2019
Title:
3-SUBSTITUTED CARBONYL-NAPHTHO[2,3-B]FURANE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
11
Patent #:
Issue Dt:
03/02/2021
Application #:
16233816
Filing Dt:
12/27/2018
Publication #:
Pub Dt:
08/08/2019
Title:
NEW TRICYCLIC QUINONE DERIVATIVE
12
Patent #:
Issue Dt:
08/13/2019
Application #:
16246829
Filing Dt:
01/14/2019
Publication #:
Pub Dt:
05/09/2019
Title:
NOVEL COMPOSITIONS AND METHODS FOR CANCER TREATMENT
13
Patent #:
NONE
Issue Dt:
Application #:
16463162
Filing Dt:
05/22/2019
Publication #:
Pub Dt:
12/12/2019
Title:
New Naphtho[2,3-B]Furan Derivatives
14
Patent #:
Issue Dt:
04/12/2022
Application #:
16464413
Filing Dt:
05/28/2019
Publication #:
Pub Dt:
04/15/2021
Title:
Naphthofuran Derivatives, Preparation, and Methods of Use Thereof
15
Patent #:
Issue Dt:
01/28/2020
Application #:
16543089
Filing Dt:
08/16/2019
Publication #:
Pub Dt:
12/26/2019
Title:
2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER
16
Patent #:
NONE
Issue Dt:
Application #:
16586049
Filing Dt:
09/27/2019
Publication #:
Pub Dt:
07/30/2020
Title:
Compositions for Treating and/or Preventing Cancer
17
Patent #:
NONE
Issue Dt:
Application #:
16841807
Filing Dt:
04/07/2020
Publication #:
Pub Dt:
12/24/2020
Title:
2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER
18
Patent #:
NONE
Issue Dt:
Application #:
16875479
Filing Dt:
05/15/2020
Publication #:
Pub Dt:
01/28/2021
Title:
Novel Group of STAT3 Pathway Inhibitors and Cancer Stem Cell Pathway Inhibitors
Assignor
1
Exec Dt:
07/01/2020
Assignee
1
640 MEMORIAL DRIVE
CAMBRIDGE, MASSACHUSETTS 02139
Correspondence name and address
DEBORAH A. MILLER
84 WATERFORD DRIVE
SUMITOMO DAINIPPON PHARMA AMERICA, INC.
MARLBOROUGH, MA 01752

Search Results as of: 05/09/2024 03:19 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT